ticlopidine has been researched along with Cardiomyopathy, Dilated in 5 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myocardial infarction was assessed using the third universal definition." | 2.82 | Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study. ( Beattie, WS; Carroll, J; Grewal, D; Harsha, P; Karkouti, K; Ragoonanan, T; Starzyk, Ł; Syed, S; Travis, G; Wąsowicz, M; Wijeysundera, DN, 2016) |
| "Pump thrombus is a potentially serious complication with few available treatment options." | 1.33 | An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent. ( Carberry, KE; Chang, AC; Dreyer, WJ; Kennedy, CE; McKenzie, ED; Moffett, BS; Morales, DL; Price, JF; Studer, MA; Teitel, ER, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalén, M | 1 |
| Sartipy, U | 1 |
| Corbascio, M | 1 |
| Lund, LH | 1 |
| Grinnemo, KH | 1 |
| Wąsowicz, M | 1 |
| Syed, S | 1 |
| Wijeysundera, DN | 1 |
| Starzyk, Ł | 1 |
| Grewal, D | 1 |
| Ragoonanan, T | 1 |
| Harsha, P | 1 |
| Travis, G | 1 |
| Carroll, J | 1 |
| Karkouti, K | 1 |
| Beattie, WS | 1 |
| Parker, T | 1 |
| Makkar, K | 1 |
| Wilensky, RL | 1 |
| Julien, MB | 1 |
| Herrmann, HC | 1 |
| Spinler, SA | 1 |
| Studer, MA | 1 |
| Kennedy, CE | 1 |
| Dreyer, WJ | 1 |
| Price, JF | 1 |
| Moffett, BS | 1 |
| Teitel, ER | 1 |
| Carberry, KE | 1 |
| Morales, DL | 1 |
| McKenzie, ED | 1 |
| Chang, AC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery[NCT01707459] | 201 participants (Actual) | Observational | 2010-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ticlopidine and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study.
Topics: Aged; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Cohort Studies; Female; Heart Diseases; Humans; | 2016 |
4 other studies available for ticlopidine and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
HeartWare left ventricular assist device thrombosis in aspirin non-responder.
Topics: Aged; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Drug Resistance; Drug Substitution; Fibrinolyti | 2014 |
Case of the month. Idiopathic dilated cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiography; Angiotensin-Converting | 2009 |
Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Cardiomyopathy, Dilated; Clopidogrel; Coronary Artery Bypass; Corona | 2006 |
An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent.
Topics: Adolescent; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Equipment Failure; Fibrinolytic Agents; H | 2006 |